{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:56:36Z","timestamp":1780059396241,"version":"3.54.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Recall urticaria is a rare hypersensitivity phenomenon characterized by the reappearance of urticarial wheals strictly confined to previously exposed skin sites following systemic re-exposure to a trigger. Although reported with several drugs, its clinical features and underlying mechanisms remain poorly defined. A 25-year-old man with ulcerative colitis developed acute pruritic wheals localized exclusively to prior subcutaneous injection sites approximately 15\u2005min after intravenous administration of vedolizumab. He had experienced repeated localized injection-site reactions during prior subcutaneous therapy. Histopathology revealed mild perivascular inflammation with eosinophils. The eruption resolved spontaneously within 24\u2005h without systemic symptoms, and vedolizumab therapy was continued. This case represents the first report of vedolizumab-associated recall urticaria. A review of previously reported cases highlights strict site specificity as the defining feature, irrespective of the route or timing of re-exposure. Recall urticaria should be recognized as a site-specific hypersensitivity reaction distinct from systemic drug allergy.<\/jats:p>","DOI":"10.3389\/falgy.2026.1781121","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:35:48Z","timestamp":1776749748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Recall urticaria caused by vedolizumab: case report and literature review"],"prefix":"10.3389","volume":"7","author":[{"given":"Mio","family":"Kozuma","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health","place":["Kitakyushu City, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health","place":["Kitakyushu City, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Sakuragi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health","place":["Kitakyushu City, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Saito-Sasaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health","place":["Kitakyushu City, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health","place":["Kitakyushu City, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0091-6749(96)70215-4","article-title":"Recall urticaria: a case report","volume":"97","author":"Karaayvaz","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1468-3083.2007.02412.x","article-title":"Recall urticaria related to levofloxacin","volume":"22","author":"Tan","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u201ctunable\u201d effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1172\/JCI31570","article-title":"Aberrant activation of integrin alpha4beta7 suppresses lymphocyte migration to the gut","volume":"117","author":"Park","year":"2007","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"835348","DOI":"10.3389\/fimmu.2022.835348","article-title":"LPS guides distinct patterns of training and tolerance in mast cells","volume":"13","author":"De Zuani","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s42003-019-0425-3","article-title":"Intravital imaging allows real-time characterization of tissue resident eosinophils","volume":"2","author":"Chojnacki","year":"2019","journal-title":"Commun Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221435","article-title":"Emerging functions of tissue-resident eosinophils","volume":"220","author":"Gurtner","year":"2023","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"269rv1","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0091-6749(94)90392-1","article-title":"Recall urticaria","volume":"93","author":"Kelso","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.anai.2023.08.001","article-title":"Recall urticaria with infusion of agalsidase beta","volume":"131","author":"Yedidi","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B12","first-page":"309","article-title":"Late recall urticaria","volume":"8","author":"Karaayvaz","year":"1998","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0091-6749(99)70143-0","article-title":"Antigen-specific recall urticaria to a peptide-based vaccine","volume":"104","author":"Rinn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"B14","first-page":"78","article-title":"Recurrent urticaria lesions in a heparin-allergic patient: most likely another form of \u201crecall urticaria\u201d","volume":"15","author":"Caliskaner","year":"2005","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2133.2009.09150.x","article-title":"Recall urticaria induced by skin tests with heparin","volume":"161","author":"Weber","year":"2009","journal-title":"Br J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaip.2017.10.031","article-title":"Recall Urticaria in Adalimumab hypersensitivity","volume":"6","author":"Li","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.18176\/jiaci.0219","article-title":"Recall Urticaria: aspirin also induces it","volume":"28","author":"Cimbollek","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.18176\/jiaci.0642","article-title":"Recall injection-site reactions after treatment with anakinra","volume":"31","author":"De Aramburu Mera","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jaip.2014.03.003","article-title":"An unusual case of recurrent \u201crecall urticaria\u201d in a patient on immunotherapy","volume":"2","author":"Ta","year":"2014","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1781121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:35:49Z","timestamp":1776749749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1781121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":19,"alternative-id":["10.3389\/falgy.2026.1781121"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2026.1781121","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1781121"}}